Literature DB >> 2164725

Mechanisms of transmissible gastroenteritis coronavirus neutralization.

C Suñé1, G Jiménez, I Correa, M J Bullido, F Gebauer, C Smerdou, L Enjuanes.   

Abstract

Transmissible gastroenteritis virus (TGEV) was neutralized more than 10(9)-fold with antibodies of a single specificity [monoclonal antibodies (MAbs)]. Most of the virus was neutralized in the first 2-3 min of a reversible reaction, which was followed by a second phase with a decreased neutralization rate and, in some cases, by a persistent fraction, which was a function of the MAb and of the antibody-to-virus ratio. Neutralization of TGEV is a specific event that requires the location of the epitope involved in the neutralization in the appropriate structural context, which is present in the wild-type virus but not in certain MAb escaping mutants. In neutralization of TGEV by binary combinations of MAbs specific for the same or for different antigenic sites, either no cooperation or a synergistic effect, respectively, was observed. Mechanisms of TGEV neutralization by MAbs were characterized at high, intermediate, and low antibody-to-virus ratios. Under these conditions, mainly three steps of the replication cycle were inhibited: binding of virus to the cell, internalization, and a step that takes place after internalization. In addition, virus aggregation could be responsible for the neutralization of 10 to 20% of virus infectivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164725      PMCID: PMC7131644          DOI: 10.1016/0042-6822(90)90521-r

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  PENETRATION OF HERPES SIMPLEX VIRUS INTO HUMAN EPIDERMOID CELLS.

Authors:  A S HUANG; R R WAGNER
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

2.  Location of antigenic sites of the S-glycoprotein of transmissible gastroenteritis virus and their conservation in coronaviruses.

Authors:  L Enjuanes; F Gebauer; I Correa; M J Bullido; C Suñé; C Smerdou; C Sánchez; J A Lenstra; W P Posthumus; R H Meloen
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

4.  Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration.

Authors:  A O Fuller; R E Santos; P G Spear
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo.

Authors:  R J Rigg; A S Carver; N J Dimmock
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

6.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

7.  Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41.

Authors:  A P Mockett; D Cavanagh; T D Brown
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

8.  Induction of transmissible gastroenteritis coronavirus-neutralizing antibodies in vitro by virus-specific T helper cell hybridomas.

Authors:  M J Bullido; I Correa; G Jiménez; C Suñé; F Gebauer; L Enjuanes
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

9.  Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells.

Authors:  D Cavanagh; P J Davis
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

Review 10.  The molecular biology of coronaviruses.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Virus Res       Date:  1983       Impact factor: 9.937

View more
  34 in total

1.  Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.

Authors:  M J Edwards; N J Dimmock
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Transgenic mice secreting coronavirus neutralizing antibodies into the milk.

Authors:  I Sola; J Castilla; B Pintado; J M Sánchez-Morgado; C B Whitelaw; A J Clark; L Enjuanes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization.

Authors:  P Gómez-Puertas; F Rodríguez; J M Oviedo; F Ramiro-Ibáñez; F Ruiz-Gonzalvo; C Alonso; J M Escribano
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies.

Authors:  J Castilla; I Sola; L Enjuanes
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity.

Authors:  B Schultze; C Krempl; M L Ballesteros; L Shaw; R Schauer; L Enjuanes; G Herrler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.

Authors:  Gregory J Babcock; Diana J Esshaki; William D Thomas; Donna M Ambrosino
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.

Authors:  Tong Zhou; Hong Wang; Danlin Luo; Thomas Rowe; Zheng Wang; Robert J Hogan; Shihong Qiu; Robert J Bunzel; Guoqiang Huang; Vinod Mishra; Thomas G Voss; Robert Kimberly; Ming Luo
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.